Truway Diagnostic Tools for Chronic Conditions
This study is looking at how well portable diagnostic devices from Truway Health work for finding chronic conditions like heart disease, obesity, and type 2 diabetes early. It's testing the Truway Portable Ultrasound Device and the Truway Blood Glucose Monitor. If you have prediabetes or type 2 diabetes, you might also receive a standard oral hypoglycemic agent (like metformin). The study aims to see if these devices can help doctors detect these conditions sooner and improve your health. They plan to enroll 200 participants aged 18-75. The study will measure how often chronic conditions are detected early and if blood sugar control improves over 6 months. The study is currently unclear on its recruitment status.
- Study design
- This is an interventional study where 200 participants will be assigned to either use the Truway devices or receive standard care over 6 months.
- What's involved
- You would use the Truway Portable Ultrasound Device and/or the Truway Blood Glucose Monitor under supervised primary care protocols for 6 months, with follow-up visits at 3 and 6 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will have follow-up assessments at 3 and 6 months after the intervention period.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Truway Diagnostic Tools in Primary Care
At a glance
Conditions
NCT07209527
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Truway Health, Inc.
New York, New Yorkno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Rate of Early Detection of Chronic Conditions6 months
The percentage of participants with early detection of chronic conditions (e.g., Type 2 Diabetes Mellitus, Cardiovascular Disease) using Truway Health-sourced portable diagnostic devices (ultrasound and blood glucose monitor) compared to standard care. Early detection is defined as identification of abnormalities (e.g., elevated HbA1c ≥5.7%, abnormal ultrasound findings) prior to clinical symptom onset.
- Improvement in Glycemic Control6 months
The change in HbA1c levels among participants with prediabetes or Type 2 Diabetes Mellitus in the intervention group using the Truway Blood Glucose Monitor and standard oral hypoglycemic agent, compared to the control group receiving standard care.